Print

Aronin receives Huntington’s Disease Society of America award

By Megan Bard

UMass Medical School Communications

July 07, 2015
  Neil Aronin receives the HDSA Research Award from HDSA CEO Louise Vetter (right) and HDSA board chair Jang-Ho Cha, MD, PhD.
  Neil Aronin receives the HDSA Research Award from HDSA CEO Louise Vetter (right) and HDSA board chair Jang-Ho Cha, MD, PhD.

Neil Aronin, MD, professor of medicine, has been honored by the Huntington’s Disease Society of America with its 2015 Research Award for his significant contributions to the understanding of the disease.

Dr. Aronin is chief of endocrinology and metabolism in the Department of Medicine and co-director of the Neurotherapeutics Institute. He is also a member of the scientific advisory boards of the Huntington’s Disease Society of America and the Hereditary Disease Foundation.

“As an enthusiastic teacher, clinician and researcher, Dr. Aronin is a pioneer in clinical science and a true champion for families affected by HD,” said Louise Vetter, CEO of the Huntington’s Disease Society of America.

Aronin has extensively researched Huntington’s disease for more than 30 years, most recently investigating the mechanisms of pathogenesis in the disease, such as mutant huntingtin mRNA kinetics, vesicle recycling and roles of proteins that interact with the expanded huntingtin protein.

He is currently focused on developing gene silencing for therapy in Huntington’s disease and is exploring viral delivery of next-generation therapeutics that could be applicable to a spectrum of autosomal dominant diseases.